Fresenius Medical Care North America Launches 2008T BlueStar Hemodialysis Machine Throughout the U.S.

(PRNewsfoto/Fresenius Medical Care North Am)
February 11, 2019 0 Comments

WALTHAM, Mass., Feb. 11, 2019 /PRNewswire/ — Fresenius Medical Care North America’s Renal Therapies Group at the moment introduced market availability of the 2008T BlueStar™ hemodialysis machine. With developed applied sciences and elevated efficiency throughout greater than 30 distinctive enhancements, the 2008T BlueStar machine represents probably the most complete improve in firm historical past. The 2008T BlueStar machine is designed to supply easier operation and upkeep with higher consumer management, resulting in potential labor and value financial savings, improved accuracy, an enhanced knowledge stream and extra therapy choices.

The 2008T BlueStar machine options numerous automated applied sciences, together with automated begin and priming mechanisms, assisted reinfusion and diminished dialysate and water utilization through idle mode, all of which assist simplify machine operation, administration and upkeep. Further enhancements equivalent to diminished preventive machine upkeep present important operational financial savings for well being methods.

“The brand new and enhanced 2008T BlueStar hemodialysis machines present greater than 30 distinctive enhancements to higher serve finish stage renal illness sufferers present process dialysis,” mentioned Mark Costanzo, President of Renal Therapies Group at Fresenius Medical Care North America. “Our new machines symbolize a major step ahead for suppliers and sufferers who depend on our life-sustaining applied sciences and an thrilling continuation of our 30-year dedication to the therapy of finish stage renal illness.”

Enhancements of the 2008T BlueStar machine embrace:

  • Auto Begin: Performs most self-tests mechanically after Auto Prime is accomplished, together with the 4 assessments that require the bloodline to be related and primed.
  • Auto Prime: Requires fewer steps and consumer touches than present priming strategies and primes the dialysate aspect of the dialyzer first, leading to much less air within the dialyzer.
  • Assisted Reinfusion: Automates the reinfusion course of through the use of the venous blood detector to detect finish of blood return.
  • Idle Mode: Reduces dialysate and water utilization by as much as two-thirds, with accompanying price financial savings.
  • Unbiased Conductivity and pH Self-Check: Makes use of the post-dialyzer conductivity cell as an impartial conductivity verify and checks the pH mechanically when the machine is utilizing an elective bibag® on-line dry bicarbonate focus.
  • Disinfection Log: Offers fast entry to a log of the final 1,200 disinfection occasions and downloads the log to a USB drive or the Medical Info System (MIS).
  • PatientCards (elective): The 2008T BlueStar expertise allows the obtain of prescription parameters from the PatientCard or MIS, probably lowering the danger for enter error.
  • Low Quantity Remedy: Permits therapy of sufferers weighing ≥ 20 kg and ≤ 40 kg.
  • Sustained Low Effectivity Dialysis (SLED): Permits acute sufferers to be dialyzed constantly over an extended time frame — as much as 12 hours.
  • Enhanced Crit-Line® Therapy Knowledge: Facilitates simplified and improved reporting and evaluation when utilizing the elective CLiC™ machine.

“Leveraging our historical past of innovation and {industry} firsts in renal care, we’re happy to unveil new options that can assist suppliers ship the best high quality of care to sufferers receiving hemodialysis each in-center and within the acute care setting,” mentioned Dr. Robert Kossmann, Chief Medical Officer for Renal Therapies Group at Fresenius Medical Care North America. “We imagine our 2008T BlueStar machine affords distinct medical benefits that streamline the complexities of hemodialysis care and improve sufferers’ total therapy expertise.”

Via the addition of latest components and up to date software program, all enhancements can be found for current 2008T hemodialysis machines by an improve course of.

For extra details about 2008T BlueStar hemodialysis machine, please go to: 2008TBlueStar.com.

INDICATIONS FOR USE

The 2008T BlueStar hemodialysis machine is indicated for acute and power dialysis remedy in a healthcare facility.

Further remedy choices for sufferers receiving hemodialysis embrace: Remoted Ultrafiltration, Sustained Low Effectivity Dialysis (SLED), and low quantity hemodialysis (sufferers weighing ≥ 20 kg and ≤ 40 kg). This machine accommodates the usage of each low- and high-flux dialyzers. The SLED remedy possibility will not be for use for sufferers weighing ≤40 kg. The 2008T and 2008T BlueStar hemodialysis machines are usually not for use for plasma alternative therapies for sufferers weighing lower than 20 kg, or for renal therapies utilizing substitution fluid.

CAUTION: Federal (U.S.) legislation restricts this machine to sale solely by or on the order of a doctor. Frequency, period and parameters of therapy are to be decided by the prescribing doctor.

NOTE: Learn the Directions for Use for protected and correct use of those gadgets. For a whole description of hazards, contraindications, unwanted side effects and precautions, see full package deal labeling at fmcna.com.

About Fresenius Medical Care North America
Fresenius Medical Care North America (FMCNA) is the premier healthcare firm targeted on offering the best high quality care to individuals with renal and different power situations. Via its industry-leading community of dialysis services, outpatient cardiac and vascular labs and pressing care facilities, Fresenius Medical Care North America gives coordinated healthcare companies at pivotal care factors for a whole lot of hundreds of chronically sick clients all through the continent. Because the world’s largest totally built-in renal firm, it affords specialty pharmacy and laboratory companies, and manufactures and distributes probably the most complete line of dialysis gear, disposable merchandise and renal prescribed drugs. For extra data, go to the FMCNA web site at https://fmcna.com.

Media Contact:

Fresenius Medical Care North America
Brad Puffer
Director of Public Relations
[email protected]
(781) 699-3331

SOURCE Fresenius Medical Care North America

Associated Hyperlinks

https://fmcna.com

Leave a Reply

Your email address will not be published. Required fields are marked *